XML 53 R2.htm IDEA: XBRL DOCUMENT v3.25.0.1
Pay vs Performance Disclosure
 12 Months Ended
Oct. 31, 2024
USD ($)
Oct. 31, 2023
USD ($)
Oct. 31, 2022
USD ($)
Oct. 31, 2021
USD ($)
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table
Fiscal
Year
SCT Total
Compensation
for PEO (1)
($)
Compensation
Actually Paid
to PEO(1) (3)
($)
Average
SCT Total Compensation
 for Other NEOs (2)
($)
Average
Compensation
Actually Paid
to Other NEOs
(2) (3)
($)
Value of Initial
Fixed $100 Investment Based On:
Net
Income (5)
(in millions)
($)
Company
Selected
Measure:
Total
Stockholder
Return (4)
($)
Peer Group
Stockholder
Return (4)
($)
Non-GAAP
EPS (6)
($)
202415,427,63139,832,9693,767,1488,460,906131.30130.04392.33.69
202313,490,92322,309,1373,462,4634,997,87297.7799.33294.23.20
202211,735,964(9,232,263)3,122,556(1,008,290)85.72102.28385.83.11
2021
10,994,90636,205,0832,772,6017,944,570130.69132.082,944.73.31
      
Company Selected Measure Name Non-GAAP EPS      
Named Executive Officers, Footnote Our PEO for all presented fiscal years was Albert G. White III.Our Other NEOs for each year were Brian G. Andrews, Daniel G. McBride, Holly R. Sheffield, and Gerard H. Warner III.      
PEO Total Compensation Amount $ 15,427,631 $ 13,490,923 $ 11,735,964 $ 10,994,906
PEO Actually Paid Compensation Amount $ 39,832,969 22,309,137 (9,232,263) 36,205,083
Adjustment To PEO Compensation, Footnote Total compensation reported for our PEO and the average compensation of the Other NEOs for each fiscal year in the 2024 SCT was adjusted in accordance with Item 402(v)(2)(iii) of Regulation S-K to calculate “compensation actually paid” as follows:
 FY 2024FY 2023FY 2022
FY 2021
CEO
($)		Average for
Other NEOs
($)		CEO
($)		Average for
Other NEOs
($)		CEO
($)		Average for
Other NEOs
($)		CEO
($)		Average for
Other NEOs
($)
SCT Total Compensation
15,427,6313,767,14813,490,9233,462,46311,735,9643,122,55610,994,906 2,772,601 
Adjustments for Equity Fair Value:
Deduct: equity award value
reported in the SCT
(12,480,056)(2,437,453)(10,569,853)(2,212,547)(9,250,214)(2,000,105)(8,499,660)(1,700,029)
Add: year-end fair value (FV) of awards granted during the FY and remaining unvested at FY end
15,357,8122,999,50111,289,4582,192,6526,953,5971,503,56218,414,8093,685,523
Add/(Deduct): change in year-end FV of prior year awards remaining unvested at FY end
18,697,7963,627,5525,603,2191,074,119(17,482,099)(3,405,635)13,119,1322,709,109
Add/(Deduct): change in FV from prior FY end of prior-year awards that vested during FY
2,910,971565,5582,487,221477,940(1,224,000)(261,639)2,193,605 493,591 
Adjustments for Pension Value:
(Deduct): aggregate change in actuarial present value of the RIP
(101,721)(83,389)(12,647)(18,474)— — (51,121)(46,458)
Add/(Deduct): prior service cost attributed to benefits under the RIP
20,53621,98920,81621,71934,48932,97133,412 30,233 
Compensation Actually Paid in FY:39,832,9698,460,90622,309,1374,997,872(9,232,263)(1,008,290)36,205,0837,944,570
Equity values are calculated in accordance with ASC 718. The SCT value of stock options relies on a Black-Scholes Model and the year-end value of stock options used for determining CAP was calculated using the Hull-White Lattice Model. For a discussion of valuation assumptions, see Note 9, Stock Plans, in our Notes to Consolidated Financial Statements included in our 2024 Annual Report. 		     
Non-PEO NEO Average Total Compensation Amount $ 3,767,148 3,462,463 3,122,556 2,772,601
Non-PEO NEO Average Compensation Actually Paid Amount $ 8,460,906 4,997,872 (1,008,290) 7,944,570
Adjustment to Non-PEO NEO Compensation Footnote Total compensation reported for our PEO and the average compensation of the Other NEOs for each fiscal year in the 2024 SCT was adjusted in accordance with Item 402(v)(2)(iii) of Regulation S-K to calculate “compensation actually paid” as follows:
 FY 2024FY 2023FY 2022
FY 2021
CEO
($)		Average for
Other NEOs
($)		CEO
($)		Average for
Other NEOs
($)		CEO
($)		Average for
Other NEOs
($)		CEO
($)		Average for
Other NEOs
($)
SCT Total Compensation
15,427,6313,767,14813,490,9233,462,46311,735,9643,122,55610,994,906 2,772,601 
Adjustments for Equity Fair Value:
Deduct: equity award value
reported in the SCT
(12,480,056)(2,437,453)(10,569,853)(2,212,547)(9,250,214)(2,000,105)(8,499,660)(1,700,029)
Add: year-end fair value (FV) of awards granted during the FY and remaining unvested at FY end
15,357,8122,999,50111,289,4582,192,6526,953,5971,503,56218,414,8093,685,523
Add/(Deduct): change in year-end FV of prior year awards remaining unvested at FY end
18,697,7963,627,5525,603,2191,074,119(17,482,099)(3,405,635)13,119,1322,709,109
Add/(Deduct): change in FV from prior FY end of prior-year awards that vested during FY
2,910,971565,5582,487,221477,940(1,224,000)(261,639)2,193,605 493,591 
Adjustments for Pension Value:
(Deduct): aggregate change in actuarial present value of the RIP
(101,721)(83,389)(12,647)(18,474)— — (51,121)(46,458)
Add/(Deduct): prior service cost attributed to benefits under the RIP
20,53621,98920,81621,71934,48932,97133,412 30,233 
Compensation Actually Paid in FY:39,832,9698,460,90622,309,1374,997,872(9,232,263)(1,008,290)36,205,0837,944,570
Equity values are calculated in accordance with ASC 718. The SCT value of stock options relies on a Black-Scholes Model and the year-end value of stock options used for determining CAP was calculated using the Hull-White Lattice Model. For a discussion of valuation assumptions, see Note 9, Stock Plans, in our Notes to Consolidated Financial Statements included in our 2024 Annual Report. 		     
Compensation Actually Paid vs. Total Shareholder Return
Relationship between CAP and TSR for the Company and the S&P 500 Healthcare Equipment Index
6047313952867
      
Compensation Actually Paid vs. Net Income
Relationship between CAP and Net Income
7696581394482
      
Compensation Actually Paid vs. Company Selected Measure
Relationship between CAP and Non-GAAP EPS
7696581394485
      
Total Shareholder Return Vs Peer Group
Relationship between CAP and TSR for the Company and the S&P 500 Healthcare Equipment Index
6047313952867
      
Tabular List, Table Revenue (Organic or Constant Currency)
•Non-GAAP EPS (Constant Currency)
•Operating Income (Constant Currency)
      
Total Shareholder Return Amount $ 131.30 97.77 85.72 130.69
Peer Group Total Shareholder Return Amount 130.04 99.33 102.28 132.08
Net Income (Loss) $ 392,300,000 $ 294,200,000 $ 385,800,000 $ 2,944,700,000
Company Selected Measure Amount 3.69 3.20 3.11 3.31
PEO Name Albert G. White III. Albert G. White III. Albert G. White III. Albert G. White III.
Additional 402(v) Disclosure Reflects cumulative total stockholder return (“TSR") of the Company and of the S&P 500 Healthcare Equipment Index assuming a $100 investment on October 31, 2019 and the reinvestment of all dividends.This column presents the Company's consolidated net income as reported in our Annual Report on Form 10-K for each covered year.      
Measure:: 1        
Pay vs Performance Disclosure        
Name Revenue      
Measure:: 2        
Pay vs Performance Disclosure        
Name Non-GAAP EPS      
Non-GAAP Measure Description Non-GAAP EPS as reported in our year-end earnings disclosures. Amounts for 2023 and 2022 have been adjusted for the 4-for-1 stock split that occurred in February 2024.      
Measure:: 3        
Pay vs Performance Disclosure        
Name Operating Income      
PEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ (101,721) $ (12,647) $ 0 $ (51,121)
PEO | Pension Adjustments Prior Service Cost        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 20,536 20,816 34,489 33,412
PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (12,480,056) (10,569,853) (9,250,214) (8,499,660)
PEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 15,357,812 11,289,458 6,953,597 18,414,809
PEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 18,697,796 5,603,219 (17,482,099) 13,119,132
PEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 2,910,971 2,487,221 (1,224,000) 2,193,605
Non-PEO NEO | Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (83,389) (18,474) 0 (46,458)
Non-PEO NEO | Pension Adjustments Prior Service Cost        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 21,989 21,719 32,971 30,233
Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (2,437,453) (2,212,547) (2,000,105) (1,700,029)
Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 2,999,501 2,192,652 1,503,562 3,685,523
Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 3,627,552 1,074,119 (3,405,635) 2,709,109
Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ 565,558 $ 477,940 $ (261,639) $ 493,591